{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T14:17:42Z","timestamp":1771510662531,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2019,6,18]],"date-time":"2019-06-18T00:00:00Z","timestamp":1560816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Region \u00d6stergotland","award":["LIO-61341"],"award-info":[{"award-number":["LIO-61341"]}]},{"name":"Region \u00f6sterg\u00f6tland","award":["LIO-127281"],"award-info":[{"award-number":["LIO-127281"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1007\/s10096-019-03608-w","type":"journal-article","created":{"date-parts":[[2019,6,18]],"date-time":"2019-06-18T02:22:05Z","timestamp":1560824525000},"page":"1765-1771","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Phenotypic screening for quinolone resistance in Escherichia coli"],"prefix":"10.1007","volume":"38","author":[{"given":"Linus","family":"Dellgren","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carina","family":"Claesson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"H\u00f6gdahl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jon","family":"Forsberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00e5kan","family":"Hanberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lennart E.","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0854-7508","authenticated-orcid":false,"given":"Anita","family":"H\u00e4llgren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,6,18]]},"reference":[{"issue":"4","key":"3608_CR1","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.eururo.2006.05.003","volume":"50","author":"S Lindstedt","year":"2006","unstructured":"Lindstedt S, Lindstrom U, Ljunggren E, Wullt B, Grabe M (2006) Single-dose antibiotic prophylaxis in core prostate biopsy: impact of timing and identification of risk factors. Eur Urol 50(4):832\u2013837. \n                    https:\/\/doi.org\/10.1016\/j.eururo.2006.05.003","journal-title":"Eur Urol"},{"issue":"10","key":"3608_CR2","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1086\/502312","volume":"25","author":"ZK Otrock","year":"2004","unstructured":"Otrock ZK, Oghlakian GO, Salamoun MM, Haddad M, Bizri AR (2004) Incidence of urinary tract infection following transrectal ultrasound guided prostate biopsy at a tertiary-care medical center in Lebanon. Infect Control Hosp Epidemiol 25(10):873\u2013877. \n                    https:\/\/doi.org\/10.1086\/502312","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"5","key":"3608_CR3","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/j.urology.2010.12.067","volume":"77","author":"OM Zaytoun","year":"2011","unstructured":"Zaytoun OM, Vargo EH, Rajan R, Berglund R, Gordon S, Jones JS (2011) Emergence of fluoroquinolone-resistant Escherichia coli as cause of postprostate biopsy infection: implications for prophylaxis and treatment. Urology 77(5):1035\u20131041. \n                    https:\/\/doi.org\/10.1016\/j.urology.2010.12.067","journal-title":"Urology"},{"issue":"4","key":"3608_CR4","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/S0090-4295(98)00296-9","volume":"52","author":"DA Kapoor","year":"1998","unstructured":"Kapoor DA, Klimberg IW, Malek GH, Wegenke JD, Cox CE, Patterson AL, Graham E, Echols RM, Whalen E, Kowalsky SF (1998) Single-dose oral ciprofloxacin versus placebo for prophylaxis during transrectal prostate biopsy. Urology 52(4):552\u2013558","journal-title":"Urology"},{"issue":"3","key":"3608_CR5","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.eururo.2012.04.044","volume":"62","author":"A Carignan","year":"2012","unstructured":"Carignan A, Roussy JF, Lapointe V, Valiquette L, Sabbagh R, Pepin J (2012) Increasing risk of infectious complications after transrectal ultrasound-guided prostate biopsies: time to reassess antimicrobial prophylaxis? Eur Urol 62(3):453\u2013459. \n                    https:\/\/doi.org\/10.1016\/j.eururo.2012.04.044","journal-title":"Eur Urol"},{"issue":"1 Suppl","key":"3608_CR6","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.1016\/j.juro.2012.11.015","volume":"189","author":"RK Nam","year":"2013","unstructured":"Nam RK, Saskin R, Lee Y, Liu Y, Law C, Klotz LH, Loblaw DA, Trachtenberg J, Stanimirovic A, Simor AE, Seth A, Urbach DR, Narod SA (2013) Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy. J Urol 189(1 Suppl):S12\u2013S17; discussion S17-18. \n                    https:\/\/doi.org\/10.1016\/j.juro.2012.11.015","journal-title":"J Urol"},{"issue":"4","key":"3608_CR7","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/j.juro.2014.04.098","volume":"192","author":"KJ Lundstrom","year":"2014","unstructured":"Lundstrom KJ, Drevin L, Carlsson S, Garmo H, Loeb S, Stattin P, Bill-Axelson A (2014) Nationwide population based study of infections after transrectal ultrasound guided prostate biopsy. J Urol 192(4):1116\u20131122. \n                    https:\/\/doi.org\/10.1016\/j.juro.2014.04.098","journal-title":"J Urol"},{"issue":"3","key":"3608_CR8","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/j.juro.2007.10.071","volume":"179","author":"J Feliciano","year":"2008","unstructured":"Feliciano J, Teper E, Ferrandino M, Macchia RJ, Blank W, Grunberger I, Colon I (2008) The incidence of fluoroquinolone resistant infections after prostate biopsy--are fluoroquinolones still effective prophylaxis? J Urol 179(3):952\u2013955; discussion 955. \n                    https:\/\/doi.org\/10.1016\/j.juro.2007.10.071","journal-title":"J Urol"},{"issue":"5\u20136","key":"3608_CR9","doi-asserted-by":"publisher","first-page":"E301","DOI":"10.5489\/cuaj.1751","volume":"8","author":"JK Rudzinski","year":"2014","unstructured":"Rudzinski JK, Kawakami J (2014) Incidence of infectious complications following transrectal ultrasound-guided prostate biopsy in Calgary, Alberta, Canada: a retrospective population-based analysis. Can Urol Assoc J 8(5\u20136):E301\u2013E305. \n                    https:\/\/doi.org\/10.5489\/cuaj.1751","journal-title":"Can Urol Assoc J"},{"issue":"2","key":"3608_CR10","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1093\/cid\/cit193","volume":"57","author":"DA Williamson","year":"2013","unstructured":"Williamson DA, Barrett LK, Rogers BA, Freeman JT, Hadway P, Paterson DL (2013) Infectious complications following transrectal ultrasound-guided prostate biopsy: new challenges in the era of multidrug-resistant Escherichia coli. Clin Infect Dis 57(2):267\u2013274. \n                    https:\/\/doi.org\/10.1093\/cid\/cit193","journal-title":"Clin Infect Dis"},{"issue":"7","key":"3608_CR11","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1007\/s00345-018-2217-7","volume":"36","author":"S Scott","year":"2018","unstructured":"Scott S, Harris PN, Williamson DA, Liss MA, Doi SAR, Roberts MJ (2018) The effectiveness of targeted relative to empiric prophylaxis on infectious complications after transrectal ultrasound-guided prostate biopsy: a meta-analysis. World J Urol 36(7):1007\u20131017. \n                    https:\/\/doi.org\/10.1007\/s00345-018-2217-7","journal-title":"World J Urol"},{"issue":"6","key":"3608_CR12","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1111\/j.1469-0691.2011.03638.x","volume":"18","author":"D Steensels","year":"2012","unstructured":"Steensels D, Slabbaert K, De Wever L, Vermeersch P, Van Poppel H, Verhaegen J (2012) Fluoroquinolone-resistant E. coli in intestinal flora of patients undergoing transrectal ultrasound-guided prostate biopsy--should we reassess our practices for antibiotic prophylaxis? Clin Microbiol Infect 18(6):575\u2013581. \n                    https:\/\/doi.org\/10.1111\/j.1469-0691.2011.03638.x","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"3608_CR13","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.jval.2017.08.3016","volume":"21","author":"K Lee","year":"2018","unstructured":"Lee K, Drekonja DM, Enns EA (2018) Cost-effectiveness of antibiotic prophylaxis strategies for transrectal prostate biopsy in an era of increasing antimicrobial resistance. Value Health 21(3):310\u2013317. \n                    https:\/\/doi.org\/10.1016\/j.jval.2017.08.3016","journal-title":"Value Health"},{"key":"3608_CR14","unstructured":"EUCAST (2019). Clinical breakpoints. \n                    http:\/\/www.eucast.org\/clinical_breakpoints\/\n                    \n                  . Last accessed 2019-01-25"},{"issue":"6","key":"3608_CR15","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1007\/s10096-018-3217-7","volume":"37","author":"I Kalalahti","year":"2018","unstructured":"Kalalahti I, Huotari K, Lahdensuo K, Tarkka E, Santti H, Rannikko A, Patari-Sampo A (2018) Rectal E. coli above ciprofloxacin ECOFF associate with infectious complications following prostate biopsy. Eur J Clin Microbiol Infect Dis 37(6):1055\u20131060. \n                    https:\/\/doi.org\/10.1007\/s10096-018-3217-7","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"4","key":"3608_CR16","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.diagmicrobio.2009.12.004","volume":"66","author":"N Karah","year":"2010","unstructured":"Karah N, Poirel L, Bengtsson S, Sundqvist M, Kahlmeter G, Nordmann P, Sundsfjord A, Samuelsen O, Norwegian Study Group on P (2010) Plasmid-mediated quinolone resistance determinants qnr and aac(6\u2032)-Ib-cr in Escherichia coli and Klebsiella spp. from Norway and Sweden. Diagn Microbiol Infect Dis 66(4):425\u2013431. \n                    https:\/\/doi.org\/10.1016\/j.diagmicrobio.2009.12.004","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"9","key":"3608_CR17","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1093\/jac\/dkt167","volume":"68","author":"A Ostholm-Balkhed","year":"2013","unstructured":"Ostholm-Balkhed A, Tarnberg M, Nilsson M, Nilsson LE, Hanberger H, Hallgren A, Travel Study Group of Southeast S (2013) Travel-associated faecal colonization with ESBL-producing Enterobacteriaceae: incidence and risk factors. J Antimicrob Chemother 68(9):2144\u20132153. \n                    https:\/\/doi.org\/10.1093\/jac\/dkt167","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"3608_CR18","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.ijantimicag.2014.11.010","volume":"45","author":"M Nawaz","year":"2015","unstructured":"Nawaz M, Sung K, Kweon O, Khan S, Nawaz S, Steele R (2015) Characterisation of novel mutations involved in quinolone resistance in Escherichia coli isolated from imported shrimp. Int J Antimicrob Agents 45(5):471\u2013476. \n                    https:\/\/doi.org\/10.1016\/j.ijantimicag.2014.11.010","journal-title":"Int J Antimicrob Agents"},{"issue":"4","key":"3608_CR19","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3109\/00365548.2012.734636","volume":"45","author":"A Ostholm Balkhed","year":"2013","unstructured":"Ostholm Balkhed A, Tarnberg M, Monstein HJ, Hallgren A, Hanberger H, Nilsson LE (2013) High frequency of co-resistance in CTX-M-producing Escherichia coli to non-beta-lactam antibiotics, with the exceptions of amikacin, nitrofurantoin, colistin, tigecycline, and fosfomycin, in a county of Sweden. Scand J Infect Dis 45(4):271\u2013278. \n                    https:\/\/doi.org\/10.3109\/00365548.2012.734636","journal-title":"Scand J Infect Dis"},{"issue":"9","key":"3608_CR20","doi-asserted-by":"publisher","first-page":"2751","DOI":"10.1128\/JCM.00456-09","volume":"47","author":"LM Cavaco","year":"2009","unstructured":"Cavaco LM, Aarestrup FM (2009) Evaluation of quinolones for use in detection of determinants of acquired quinolone resistance, including the new transmissible resistance mechanisms qnrA, qnrB, qnrS, and aac(6')Ib-cr, in Escherichia coli and Salmonella enterica and determinations of wild-type distributions. J Clin Microbiol 47(9):2751\u20132758. \n                    https:\/\/doi.org\/10.1128\/JCM.00456-09","journal-title":"J Clin Microbiol"},{"issue":"11","key":"3608_CR21","doi-asserted-by":"publisher","first-page":"3411","DOI":"10.1128\/JCM.01287-15","volume":"53","author":"R Skov","year":"2015","unstructured":"Skov R, Matuschek E, Sjolund-Karlsson M, Ahman J, Petersen A, Stegger M, Torpdahl M, Kahlmeter G (2015) Development of a pefloxacin disk diffusion method for detection of fluoroquinolone-resistant Salmonella enterica. J Clin Microbiol 53(11):3411\u20133417. \n                    https:\/\/doi.org\/10.1128\/JCM.01287-15","journal-title":"J Clin Microbiol"},{"issue":"10","key":"3608_CR22","doi-asserted-by":"publisher","first-page":"4292","DOI":"10.1128\/AAC.01664-08","volume":"53","author":"N Allou","year":"2009","unstructured":"Allou N, Cambau E, Massias L, Chau F, Fantin B (2009) Impact of low-level resistance to fluoroquinolones due to qnrA1 and qnrS1 genes or a gyrA mutation on ciprofloxacin bactericidal activity in a murine model of Escherichia coli urinary tract infection. Antimicrob Agents Chemother 53(10):4292\u20134297. \n                    https:\/\/doi.org\/10.1128\/AAC.01664-08","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"3608_CR23","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1093\/jac\/dkt063","volume":"68","author":"J Dominguez-Herrera","year":"2013","unstructured":"Dominguez-Herrera J, Velasco C, Docobo-Perez F, Rodriguez-Martinez JM, Lopez-Rojas R, Briales A, Pichardo C, Diaz-de-Alba P, Rodriguez-Bano J, Pascual A, Pachon J (2013) Impact of qnrA1, qnrB1 and qnrS1 on the efficacy of ciprofloxacin and levofloxacin in an experimental pneumonia model caused by Escherichia coli with or without the GyrA mutation Ser83Leu. J Antimicrob Chemother 68(7):1609\u20131615. \n                    https:\/\/doi.org\/10.1093\/jac\/dkt063","journal-title":"J Antimicrob Chemother"},{"issue":"12","key":"3608_CR24","doi-asserted-by":"publisher","first-page":"5830","DOI":"10.1128\/AAC.01489-13","volume":"57","author":"T Guillard","year":"2013","unstructured":"Guillard T, Cambau E, Chau F, Massias L, de Champs C, Fantin B (2013) Ciprofloxacin treatment failure in a murine model of pyelonephritis due to an AAC(6\u2032)-Ib-cr-producing Escherichia coli strain susceptible to ciprofloxacin in vitro. Antimicrob Agents Chemother 57(12):5830\u20135835. \n                    https:\/\/doi.org\/10.1128\/AAC.01489-13","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"3608_CR25","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1089\/mdr.2011.0040","volume":"17","author":"HS Jeong","year":"2011","unstructured":"Jeong HS, Bae IK, Shin JH, Kim SH, Chang CL, Jeong J, Kim S, Lee CH, Ryoo NH, Lee JN (2011) Fecal colonization of Enterobacteriaceae carrying plasmid-mediated quinolone resistance determinants in Korea. Microb Drug Resist 17(4):507\u2013512. \n                    https:\/\/doi.org\/10.1089\/mdr.2011.0040","journal-title":"Microb Drug Resist"},{"issue":"2","key":"3608_CR26","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1128\/AAC.01051-08","volume":"53","author":"HB Kim","year":"2009","unstructured":"Kim HB, Park CH, Kim CJ, Kim EC, Jacoby GA, Hooper DC (2009) Prevalence of plasmid-mediated quinolone resistance determinants over a 9-year period. Antimicrob Agents Chemother 53(2):639\u2013645. \n                    https:\/\/doi.org\/10.1128\/AAC.01051-08","journal-title":"Antimicrob Agents Chemother"},{"key":"3608_CR27","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.drup.2016.09.001","volume":"29","author":"JM Rodriguez-Martinez","year":"2016","unstructured":"Rodriguez-Martinez JM, Machuca J, Cano ME, Calvo J, Martinez-Martinez L, Pascual A (2016) Plasmid-mediated quinolone resistance: two decades on. Drug Resist Updat 29:13\u201329. \n                    https:\/\/doi.org\/10.1016\/j.drup.2016.09.001","journal-title":"Drug Resist Updat"},{"issue":"11","key":"3608_CR28","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.1128\/AAC.38.11.2623","volume":"38","author":"K Hoshino","year":"1994","unstructured":"Hoshino K, Kitamura A, Morrissey I, Sato K, Kato J, Ikeda H (1994) Comparison of inhibition of Escherichia coli topoisomerase IV by quinolones with DNA gyrase inhibition. Antimicrob Agents Chemother 38(11):2623\u20132627","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl 2","key":"3608_CR29","doi-asserted-by":"publisher","first-page":"S120","DOI":"10.1086\/428052","volume":"41","author":"GA Jacoby","year":"2005","unstructured":"Jacoby GA (2005) Mechanisms of resistance to quinolones. Clin Infect Dis 41(Suppl 2):S120\u2013S126. \n                    https:\/\/doi.org\/10.1086\/428052","journal-title":"Clin Infect Dis"},{"key":"3608_CR30","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1471-2334-13-8","volume":"13","author":"Y Fu","year":"2013","unstructured":"Fu Y, Zhang W, Wang H, Zhao S, Chen Y, Meng F, Zhang Y, Xu H, Chen X, Zhang F (2013) Specific patterns of gyrA mutations determine the resistance difference to ciprofloxacin and levofloxacin in Klebsiella pneumoniae and Escherichia coli. BMC Infect Dis 13:8. \n                    https:\/\/doi.org\/10.1186\/1471-2334-13-8","journal-title":"BMC Infect Dis"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-019-03608-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-019-03608-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-019-03608-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T10:37:35Z","timestamp":1567075055000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-019-03608-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,18]]},"references-count":30,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["3608"],"URL":"https:\/\/doi.org\/10.1007\/s10096-019-03608-w","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,18]]},"assertion":[{"value":"19 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Regional Ethical Review Board in Link\u00f6ping, Sweden, approved the study (ref. nos. 2012\/2019-31 and 2015\/68-32).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}